Search - tctmd.com

Displaying 61 - 80 of 370

Sort: Relevancy | Date

News Daily News

Oxidized Phospholipids and Lp(a) Strongly Associated With MACE: CASABLANCA

Michael O'Riordan

May 03, 2023

News Daily News

REPRIEVE Stopped: Big MACE Reductions With Statins in HIV+ Subjects

Shelley Wood

April 12, 2023

News Conference News ACC 2023

CRP More Predictive of Future Events Than LDL in Statin-Treated Patients

Caitlin E. Cox

March 14, 2023

News Conference News ACC 2023

Oral PCSK9 Inhibitor Reduces LDL Cholesterol in Phase IIb Study

Todd Neale

March 10, 2023

News Conference News ACC 2023

MASTER@HEART: Long-term Endurance Athletes Not Immune to Atherosclerosis

Michael O'Riordan

March 10, 2023

News Conference News ACC 2023

Stable CAD Plaque Morphology Improved by PCSK9 Inhibitors: YELLOW III

Shelley Wood

March 04, 2023

News Daily News

Maternal CV Risk After Adverse Pregnancy Outcome Can Last Over 40 Years

L.A. McKeown

February 13, 2023

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for January 2023

Caitlin E. Cox

February 01, 2023

News Daily News

UK’s NICE Recommends Lower-Risk Thresholds for Statin Therapy

Michael O'Riordan

January 20, 2023

News Daily News

How Lp(a) Levels Compare With LDL-C in FH: Some Surprises

Michael O'Riordan

November 17, 2022

News Daily News

New Risk Models Superior to Pretest Probability at Predicting CAD

Yael L. Maxwell

November 15, 2022

News Conference News AHA 2022

Pemafibrate Fails to Lower CVD Risk in Patients With High Triglycerides: PROMINENT

Michael O'Riordan

November 05, 2022

News Daily News

SCAD in Men: Canadian Study Sheds Light on Rare Condition

Caitlin E. Cox

October 25, 2022

News Conference News TCT 2022

PCSK9 Inhibitors Before PCI Swiftly Lower LDL-C in ACS Patients: EPIC-STEMI

Shelley Wood

September 22, 2022

Presentation TCT 2022

TCT 761: Multivessel Coronary Artery Thrombus in the Absence of Obstructive Coronary Atherosclerosis, a Potential Role for CCTA

Presenter: Brent Klinkhammer

September 18, 2022

Presentation TCT 2022

TCT 57: Everolimus-eluting Bioresorbable Vascular Scaffolds for Coronary Atherosclerosis Restoration Therapy: Insights on Long-term Intracoronary Imaging and Physiological Results of Bioresorption

Presenter: Gabriele Pesarini

September 17, 2022

News Conference News TCT 2022

Primordial Prevention Before End-stage CVD: Experts Call for a Fresh Focus

Yael L. Maxwell

September 16, 2022

News Conference News ESC 2022

Factor XIa Inhibitors Show Potential for Safer Anticoagulation After MI, Stroke

Todd Neale

August 28, 2022

News Conference News ESC 2022

ALL-HEART: Gout Drug Allopurinol No Help in CV Prevention

Shelley Wood

August 27, 2022

News Features

Novel Targets, Gene Edits, and Vaccines: Is a ‘Golden Era’ Dawning for ASCVD?

Michael O'Riordan

August 15, 2022

Advertisement

Oxidized Phospholipids and Lp(a) Strongly Associated With MACE: CASABLANCA

REPRIEVE Stopped: Big MACE Reductions With Statins in HIV+ Subjects

CRP More Predictive of Future Events Than LDL in Statin-Treated Patients

Oral PCSK9 Inhibitor Reduces LDL Cholesterol in Phase IIb Study

MASTER@HEART: Long-term Endurance Athletes Not Immune to Atherosclerosis

Stable CAD Plaque Morphology Improved by PCSK9 Inhibitors: YELLOW III

Maternal CV Risk After Adverse Pregnancy Outcome Can Last Over 40 Years

TCTMD’s Top 10 Most Popular Stories for January 2023

UK’s NICE Recommends Lower-Risk Thresholds for Statin Therapy

How Lp(a) Levels Compare With LDL-C in FH: Some Surprises

New Risk Models Superior to Pretest Probability at Predicting CAD

Pemafibrate Fails to Lower CVD Risk in Patients With High Triglycerides: PROMINENT

SCAD in Men: Canadian Study Sheds Light on Rare Condition

PCSK9 Inhibitors Before PCI Swiftly Lower LDL-C in ACS Patients: EPIC-STEMI

TCT 761: Multivessel Coronary Artery Thrombus in the Absence of Obstructive Coronary Atherosclerosis, a Potential Role for CCTA

TCT 57: Everolimus-eluting Bioresorbable Vascular Scaffolds for Coronary Atherosclerosis Restoration Therapy: Insights on Long-term Intracoronary Imaging and Physiological Results of Bioresorption

Primordial Prevention Before End-stage CVD: Experts Call for a Fresh Focus

Factor XIa Inhibitors Show Potential for Safer Anticoagulation After MI, Stroke

ALL-HEART: Gout Drug Allopurinol No Help in CV Prevention

Novel Targets, Gene Edits, and Vaccines: Is a ‘Golden Era’ Dawning for ASCVD?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content